Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Infliximab Using a Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Strand, Vibeke [1 ]
Mease, Philip J. [2 ,3 ]
McInnes, Iain B. [4 ]
Nash, Peter [5 ]
Thom, Howard [6 ]
Hunger, Matthias [7 ]
Gandhi, Kunal [8 ]
Mpofu, Shephard [9 ]
Jugl, Steffen [9 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[2] Swedish Med Ctr, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Glasgow, Glasgow, Lanark, Scotland
[5] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[6] Univ Bristol, Bristol, Avon, England
[7] MAPI Grp, Munich, Germany
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1729
引用
收藏
页数：2
相关论文
共 50 条
  • [31] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Tahir, Hasan
    Maksymowych, Walter
    Choy, Ernest
    Yazici, Yusuf
    Walsh, Jessica
    Thom, Howard
    Kalyvas, Chrysostomos
    Fox, Todd
    Gandi, Kunal
    Jugl, Steffen
    RHEUMATOLOGY, 2018, 57
  • [32] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Maksymowych, W.
    Choy, E.
    Yazici, Y.
    Walsh, J.
    Thom, H.
    Kalyvas, C.
    Fox, T.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1301 - 1301
  • [33] Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
    Maksymowych, Walter P.
    Thom, Howard
    Morup, Michael F.
    Taieb, Vanessa
    Willems, Damon
    Lyris, Nikos
    Gaffney, Karl
    RHEUMATOLOGY AND THERAPY, 2024, 11 (04) : 1023 - 1041
  • [34] A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF BIMEKIZUMAB AND SECUKINUMAB AT 52 WEEKS FOR THE TREATMENT OF RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    Maksymowych, W. P.
    Thom, H.
    Morup, M.
    Taieb, V
    Willems, D.
    Gaffney, K.
    VALUE IN HEALTH, 2023, 26 (12) : S30 - S30
  • [35] Comparison of Secukinumab Vs Adalimumab in a Cost per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthritis at 48 Weeks from the US Perspective
    Greenberg, Jeffrey D.
    Nikoglou, Efthalia
    Gunda, Praveen
    Palmer, Jacqueline
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [36] Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis
    Cohan, Stanley
    Tencer, Tom
    Arndorfer, Stella
    Zhu, Xuelian
    Zivkovic, Marko
    Kumar, Jinender
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [37] Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
    Garcia-Foncillas, J.
    Bokemeyer, C.
    Italiano, A.
    Keating, K.
    Paracha, N.
    Fellous, M.
    Marian, M.
    Fillbrunn, M.
    Gao, W.
    Ayyagari, R.
    Lassen, U. N.
    ANNALS OF ONCOLOGY, 2021, 32 : S401 - S401
  • [38] Matching-adjusted indirect comparisons of ixekizumab and secukinumab using etanercept and ustekinumab bridge comparators
    Wu, J. J.
    Saure, D.
    Schacht, A.
    Mallbris, L.
    Wilhelm, S.
    Dossenbach, M.
    Burkhardt, N.
    Nast, A.
    Warren, R. B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 44 - 44
  • [39] Matching-adjusted indirect comparisons of Ixekizumab and Secukinumab using Etanercept and Ustekinumab Bridge Comparators
    Wu, J.
    Saure, D.
    Schacht, A.
    Mallbris, L.
    Wilhelm, S.
    Dossenbach, M.
    Nast, A.
    Warren, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S58 - S58
  • [40] Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis
    Fox, Robert J.
    Chan, Andrew
    Zhang, Annie
    Xiao, James
    Levison, Dane
    Lewin, James B.
    Edwards, Michael R.
    Marantz, Jing L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (02) : 175 - 183
12345